Lifecore Biomedical Inc (NASDAQ: LFCR) stock suffered a major decline of -30.3% on 3/20/24. The shares closed at $5.01. Moreover, this decline was accompanied by exceptionally high trading volume at 1697% of normal. Relative to the market the stock has been weak over the last nine months and has declined -35.5% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, LFCR is expected to be a major Value Eraser.
Lifecore Biomedical is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment